POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES (latest WHO data):   U.S. 133,475    India 18,711    Brazil 75,495    Russia 11,022    The United Kingdom 5,946    France 22,725    Italy 24,010    Turkey 11,302    Germany 9,557    Columbia 3,371    Argentina 4,860    Mexico 6,797    Iran 8,212    South Africa 1,313    Ukraine 9,144    Indonesia 5,767    Peru 8,447    Czechia 13,162    The Netherlands 4,727    Canada 3,370    Chile 5,033    Romania 4,342    Portugal 1,489    Iraq 4,068    Sweden 4,811    Philippines 3,434    Pakistan 1,714    Serbia 4,071    Austria 2,319    Hungary 7,269    Japan 1,064    Jordan 3,481    United Arab Emirates 2,959    Lebanon 3,158    Slovakia 2,522    Malaysia 1,680    Belarus 1,480    Ecuador 1,873    Bulgaria 3,004    Palestine 2,011    Greece 2,181    Kuwait 1,318    Moldova 1,788    Guatemala 1,461    Paraguay 1,501    Ethiopia 1,118    Estonia 1,540    China 28    Singapore 13    New Zealand 1    Australia 10    South Korea 416   

Lifesaving drugs in short supply in U.S., says FDA

Staff Writer |
The U.S. Food and Drug Administration said Friday that it's working with the drug company Pfizer to remedy a shortage of important injectable medications, including emergency syringes of epinephrine.

Article continues below






Epinephrine treats anaphylaxis, a severe allergic reaction to bee stings and foods such as peanuts.

The drugs in short supply are made by the Pfizer company Hospira. In some cases, the FDA is extending expiration dates.

"These are all critically important drugs for treating patients with life-threatening conditions," said Dr. Robert Glatter, an emergency physician at Lenox Hill Hospital in New York City.

The conditions these drugs treat include cardiac arrest (when the heart suddenly stops); a chemical imbalance in the blood called metabolic acidosis; and abnormal heart rhythms, Glatter said.

"The reality is this: There is no substitute for medications such as epinephrine in the setting of anaphylaxis, angioedema, and patients in cardiac arrest," Glatter said. "The end result may be death." Angioedema is swelling that can occur as part of a serious allergic reaction.

Besides epinephrine, the drugs include vials and syringes of sodium bicarbonate and dextrose 50 percent injections, as well as emergency syringes of calcium chloride and atropine sulfate.

Pfizer blames the shortage on manufacturing, distribution and third-party delays, the FDA said.

"We are working closely with Pfizer to resolve these critical shortages by addressing the underlying causes," the agency said in a news release.

The FDA said it's seeking alternative manufacturers, and weighing whether to expedite review of new applications.

The FDA has also extended expiration dates on certain lots of emergency syringes, so that health care professionals can continue using them during the shortage.

If replacement syringes become available during the extension period, the FDA said the older lots should be disposed of as soon as possible.

"We will update the public as the situation changes. Continue to visit the drug shortages webpage for more information on approved sources of these drug products," the agency said.


What to read next

Men, avoid impotence drugs before surgery
Cancer drugs enter European market without evidence of survival or life quality benefit
Generic drugs are as effective as branded and cost less